sPLA 2 s (secretory phospholipases A 2 ) belong to a broad and structurally diverse family of enzymes that hydrolyse the sn-2 ester bond of glycerophospholipids. We previously showed that a secreted fungal 15 kDa protein, named p15, as well as its orthologue from Streptomyces coelicolor (named Scp15) induce neurite outgrowth in PC12 cells at nanomolar concentrations. We report here that both p15 and Scp15 are members of a newly identified group of fungal/bacterial sPLA 2 s. The phospholipid-hydrolysing activity of p15 is absolutely required for neurite outgrowth induction. Mutants with a reduced PLA 2 activity exhibited a comparable reduction in neurite-inducing activity, and the ability to induce neurites closely matched the capacity of various p15 forms to promote fatty acid release from live PC12 cells. A structurally divergent member of the sPLA 2 family, bee venom sPLA 2 , also induced neurites in a phospholipase activity-dependent manner, and the same effect was elicited by mouse group V and X sPLA 2 s, but not by group IB and IIA sPLA 2 s. Lysophosphatidylcholine, but not other lysophospholipids, nor arachidonic acid, elicited neurite outgrowth in an L-type Ca 2+ channel activity-dependent manner. In addition, p15-induced neuritogenesis was unaffected by various inhibitors that block arachidonic acid conversion into bioactive eicosanoids. Altogether, these results delineate a novel, Ca 2+ -and lysophosphatidylcholine-dependent neurotrophin-like role of sPLA 2 s in the nervous system.
sPLA 2 s (secretory phospholipases A 2 ) belong to a broad and structurally diverse family of enzymes that hydrolyse the sn-2 ester bond of glycerophospholipids. We previously showed that a secreted fungal 15 kDa protein, named p15, as well as its orthologue from Streptomyces coelicolor (named Scp15) induce neurite outgrowth in PC12 cells at nanomolar concentrations. We report here that both p15 and Scp15 are members of a newly identified group of fungal/bacterial sPLA 2 s. The phospholipid-hydrolysing activity of p15 is absolutely required for neurite outgrowth induction. Mutants with a reduced PLA 2 activity exhibited a comparable reduction in neurite-inducing activity, and the ability to induce neurites closely matched the capacity of various p15 forms to promote fatty acid release from live PC12 cells. A structurally divergent member of the sPLA 2 family, bee venom sPLA 2 , also induced neurites in a phospholipase activity-dependent manner, and the same effect was elicited by mouse group V and X sPLA 2 s, but not by group IB and IIA sPLA 2 s. Lysophosphatidylcholine, but not other lysophospholipids, nor arachidonic acid, elicited neurite outgrowth in an L-type Ca 2+ channel activity-dependent manner. In addition, p15-induced neuritogenesis was unaffected by various inhibitors that block arachidonic acid conversion into bioactive eicosanoids. Altogether, these results delineate a novel, Ca 2+ -and lysophosphatidylcholine-dependent neurotrophin-like role of sPLA 2 s in the nervous system.
INTRODUCTION
Rat pheochromocytoma PC12 cells have been extensively utilized as a model system to study the intracellular signalling pathway(s) leading to neuronal differentiation. Stimulation by differentiation factors such as NGF (nerve growth factor) and subsequent activation of its receptor, TrkA, initiates a variety of signalling events that lead to cessation of growth, acquirement of electrical excitability, expression of neuron-specific marker proteins and neurite extension. Besides growth factor stimulation, Ca 2+ influx through voltage-gated Ca 2+ channels upon membrane depolarization also induces neuronal differentiation. Neurite extension induced by various kinds of stimuli, such as growth factors and depolarization, is a characteristic signature of neuronal differentiation. Ca 2+ influx through voltage-gated channels, followed by an increase in intracellular Ca 2+ , initiates a variety of cellular events leading to neurite outgrowth via the concerted action of various Ca 2+ -binding proteins [1] . For example, calmodulin activation in growth cones leads to the formation of an active calcineurin form that is implicated in the dephosphorylation of the microtubule-associated protein tau and in promoting tubulin assembly. Elevation of intracellular Ca 2+ levels also stimulates the expression of several Ca 2+ -regulated genes, such as c-fos and brain-derived neurotrophic factor, through the activation of the Ras-MAPK (mitogen-activated protein kinase) cascade.
It has also been found that homophilic interaction of CAMs (cell adhesion molecules) stimulate a neurite outgrowth response that is dependent on the activity of L-and N-type Ca 2+ channels.
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Co-culture of PC12 cells or cerebellar neurons on a monolayer of fibroblasts expressing neural CAM or N-cadherin leads to neurite extension through interaction with CAMs exposed on the surface of neighbouring support cells [2, 3] . The second messenger pathway underlying CAM-induced neurite outgrowth has been analysed in detail. It has been shown, for example, that stimulation by CAMs leads to the phosphorylation and activation of the fibroblast growth factor receptor, which in turn transmits its signal to phospholipase Cγ [4] . Activated phospholipase Cγ hydrolyses phospholipids to produce diacylglycerol, which then serves as a substrate for the production of arachidonic acid through the action of diacylglycerol lipase. Arachidonic acid has thus been suggested to induce an influx of Ca 2+ through plasma membrane-associated Ca 2+ channels, ultimately leading to neurite outgrowth. The direct addition of arachidonic acid to the culture medium, however, did not cause any increase in steady-state Ca 2+ levels in neuronal growth cones [5] . sPLA 2 s (secretory phospholipases A 2 ) are enzymes of 13-20 kDa that hydrolyse the ester bond at the sn-2 position of glycerophospholipids in a Ca 2+ -dependent manner [6, 7] . The first members of this family of enzymes were identified in pancreatic juice and snake venoms. After decades of study, it has been recognized that sPLA 2 s belong to a broad, structurally and functionally diverse family of proteins [6, 7] , that are present in various venoms as well as in animal organs (but also in filamentous bacteria and fungi [8, 9] ), and are endowed with a variety of proinflammatory, neurotoxic, myotoxic, cardiotoxic and other stressresponse-inducing properties [10, 11] . An increasing number of novel cellular sPLA 2 s is being identified as the result of completed or ongoing whole genome sequencing projects. They are currently classified into eight different groups, I, II, III, V, IX, X, XI and XII, according to their primary structures and biochemical properties [6, 7] . In mammals, sPLA 2 s not only function as phospholipiddigesting enzymes, but are also involved in the production of signalling molecules, especially arachidonic acid, a key precursor of various eicosanoids including prostaglandins, thromboxanes and leukotrienes [7, 12] .
We reported previously the identification of a secreted 15 kDa fungal protein, named p15, with a potent neurite-inducing activity on PC12 cells [13, 14] . Amino acid sequence analysis of p15 followed by a database search revealed the presence of a p15 homologue in Streptomyces coelicolor A3 (2) , that also displays neurite-inducing activity in PC12 cells [15] . We show here that these two proteins are novel members of a recently defined fungal/bacterial sPLA 2 group (XIII) [8, 9] and that their sn-2 position-specific phospholipase activity is absolutely required for neurite outgrowth induction. sPLA 2 -induced neuritogenesis was specifically blocked by the L-type Ca 2+ channel blocker nicardipine, but not by inhibitors of eicosanoid-synthesizing enzymes. In the absence of exogenously supplied sPLA 2 , neurite outgrowth was elicited by lysophosphatidylcholine (lysoPC), but not by other lysophospholipids, nor by arachidonic acid. Altogether, these results point to the involvement of sPLA 2 s in a novel cellular pathway leading to neuronal differentiation.
EXPERIMENTAL

Materials
The high-fidelity, thermostable Pfx DNA polymerase used for DNA amplification, the expression vector pRSET-C and Lipofectamine 2000 reagent for the transfection of COS1 cells were from Invitrogen. Amplified DNA fragments were purified with GeneClean II (Bio101 2 ; Sigma catalogue no. P 9279), nicardipine (N 7510), arachidonic acid (A 9673), aspirin (A 5376), indomethacin (I 7378), nordihydroguaiaretic acid (NDGA; N 5023), AA-861 (N 3711), dipalmitoyl-sn-glycerophosphatidylcholine, 1-palmitoyl-2-lynoleyl phosphatidylcholine, 1-palmitoyl-2-lynoleyl phosphatidylethanolamine, 1-palmitoyl-sn-glycero-3-phosphocholine (lysoPC; L 5245), sphingosylphosphorylcholine (S 4257), lysophosphatidylinositol (L 7635), lysophosphatidylethanolamine (L 4754), lysophosphatidylserine (L 3401) and 1-oleyl-sn-glycero-3-phosphate (L 7260) were from Sigma. Baicalein was purchased from Aldrich (46,511-9), and mcPAF (methylcarbamyl plateletactivating factor C-16) was from Cayman (catalogue no. 60908).
cDNA cloning and expression of bvPLA 2 and mouse sPLA 2 s A full-length cDNA coding for the N-terminally processed form of bvPLA 2 was PCR-amplified using reverse-transcribed total RNA from the venom gland of honey bee as a template (S. Nakashima, K. Kitamoto and M. Arioka, unpublished work; details can be obtained from the corresponding author on request), and the following oligonucleotide primers: 5 -cgagttggagctgcag-ATAATATATCCGGAACGTT-3 (forward); 5 -cgtgaaagcttTCA-TACTTGCGAAGATCGA-3 (reverse; uppercase letters indicate the cDNA sequences coding for the two ends of the mature bvPLA 2 polypeptide; the PstI and HindIII sites are underlined). The cDNA obtained from such an amplification reaction was digested with PstI and HindIII, and ligated to the corresponding site of the pRSET-C vector. The resulting construct, pRSETbvPLA 2 , was transformed into Escherichia coli BL21 (DE3) pLysS cells (Invitrogen), which were then induced to express rbvPLA 2 (recombinant bvPLA 2 ) as described previously [14] . After cell lysis, the insoluble fraction was pelleted by centrifugation, solubilized with 6 M guanidine/HCl (pH 7.8), and applied to a Ni 2+ -nitrilotriacetate agarose column, which was utilized for rbvPLA 2 purification following the manufacturer's instructions. Purified rbvPLA 2 was renatured according to previously reported procedures [16, 17] .
Mouse group IB (accession no. AF162712), IIA (AF162712), V (AF162713) and X (AF166097) cDNAs were amplified by PCR using Pfx DNA polymerase and mouse cDNA libraries from adult pancreas (IB and IIA) or fetal brain (V and X) as templates. The following oligonucleotides were utilized as amplification primers: 5 -agaattcgccaccATGAAACTCCTTCTGCTGGCTGCTC-3 and 5 -gcacagatctccACAGAATTTCCCGGTGTCAAGGTTT-3 for the group IB sPLA 2 ; 5 -agaattcgccaccATGAAGGTCCTCCTGC-TGCTAGCAG-3 and 5 -gcatagatctccGCATTTGGGCTTCTTC-CCTTTGCAA-3 for the group IIA sPLA 2 ; 5 -gaattcgccacc-ATGAAGGGTCTCCTCACA-3 and 5 -atgcagatctgcGCAGAG-GAAGTTGGGGTAATAC-3 for the group V sPLA 2 ; 5 -gaattcgccaccATGCTGCTGCTACTGCTG-3 and 5 -atgcagatctgcAT-TGCACTTGGGAGAGTCCTTC-3 for the group X sPLA 2 . Capital letters correspond to the coding regions, and lower-case underlined sequences identify the EcoRI and BglII sites used for cDNA cloning. Amplified cDNA fragments were digested with EcoRI and BglII, and ligated to the pMT vector for expression in COS1 cells. The pMT vector is a derivative of pME18S (kindly provided by Dr K. Maruyama, Department of Virology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan), that was modified in this laboratory so as to allow the expression of recombinant proteins tagged at the C-terminus with HA (haemagglutinin) and with a stretch of six histidines (His 6 ; M. Arioka, unpublished work; details can be obtained from the corresponding author on request). Recombinant proteins expressed from this vector contain the sequence G(or A)DLYPYDVPDYASHHHHHH (the HA epitope is underlined) as a C-terminal extension. Individual sPLA 2 constructs were transfected into COS1 cells by lipofection. Equal volumes of culture supernatants, recovered 3 days after transfection, were examined by immunoblot analysis before being assayed for neuritogenic activity in PC12 cells. Immunoblot analysis was performed with the SuperSignal Substrate Western blotting kit (Pierce), using the anti-HA antibody (Roche) and a peroxidaselabelled anti-mouse IgG secondary antibody (PI-2000; Vector).
Site-directed mutagenesis
A PCR-based mutagenesis protocol was used to generate the H34A mutant of bvPLA 2 . Using the pRSET-bvPLA 2 plasmid as a template, mutated DNA fragments were first amplified by PCR using the following pairs of vector-annealing and mutagenic oligonucleotides as primers: T7 (5 -TAATACGACTCACTA-TAGGG-3 )/mutant antisense (5 -GCACATGTCGGCGGTTCG-ACA-3 ) and pRSET RV (5 -TAGTTATTGCTCAGCGGTGG-3 )/ mutant sense (5 -TGTCGAACCGCCGACATGTGC-3 ; where the underlined sequence corresponds to the His-to-Ala mutation). The two resulting PCR fragments were mixed, followed by a second amplification reaction, carried out with the T7 and pRSET RV primers, to generate the His 6 -tagged H34A mutant version of rbvPLA 2 . The amplicon thus obtained was then digested with PstI and HindIII and ligated to the corresponding site of pRSET C.
A similar strategy was employed to generate the H47A (group V) and H46A (group X) active-site mutants of mouse sPLA 2 s. The mutagenic primers were: 5 -TGTCAGATGgcCGAtCGTTGT-3 and 5 -ACAACGaTCGgcCATCTGACA-3 for the H47A mutant; and 5 -TGCTACCACgcCGACTGCTGC-3 and 5 -GCAGCAGTCGgcGTGGTAGCA-3 for H46A mutant. Mutated nucleotides are indicated by lower-case letters, with the replaced (Histo-Ala) codons underlined.
A distinct PCR-based mutagenesis protocol was used to generate the HDAA and D107A mutants of p15. The pRSETCp15 plasmid, previously utilized to express His 6 -p15 and to produce the C38/54S and C90/102S mutants [14] , was employed as a template for mutagenic PCR in combination with the following sets of oligonucleotide primers: for the HDAA mutation, 5 -TGCCACCGCGCTGCCTTCGGCTACCGC-3 (forward) and 5 -AGAGGATAAGAAGTCGAAGCCGAATGG-3 (reverse) primers; for the D107A mutation, 5 -GCCGTTGCCGCTATCT-ACTACGAG-3 (forward) and 5 -TTTGCAGGCAGCTCTTG-TGAAGAT-3 (reverse) primers [where the underlined sequences indicate the His-57-to-Ala/Asp-58-to-Ala (HDAA) and the Asp-107-to-Ala (D107A) mutations, respectively]. All His 6 -p15 mutant proteins, as well as wild-type His 6 -p15 and His 6 -Scp15, were expressed in E. coli BL21 (DE3) pLysS cells and purified by Ni 2+ -affinity chromatography under denaturing conditions as described previously [14] .
Phospholipase activity assays
Three different assays were used to measure phospholipase activity. The first assay employed [ 3 H]oleic acid-labelled E. coli membranes as a substrate [18] . Approx. 4.8 × 10 5 d.p.m. equivalents of [ 3 H]oleic acid-labelled E. coli membranes were incubated with 10 nM His 6 -p15 in 100 µl reaction mixtures containing 25 mM Tris/HCl (pH 7.4) and various concentrations (0-100 mM) of CaCl 2 for 2 h at 37
• C. An equal volume of 1 mg/ml BSA was then added, mixed by vortexing, followed by centrifugation at 18 500 g for 3 min. Aliquots of the resulting supernatants (100 µl each) were mixed with 1 ml of scintillation cocktail [0.55 % 2,5-diphenyloxazole, 0.01 % 1,4-bis(4-methyl-5-phenyl-2-oxazoly)benzene in 33.3 % (v/v) Triton X-100 and 66.7 % (v/v) toluene] and counted by liquid scintillation. A second type of assay, carried out with a commercially available sPLA 2 assay kit (Cayman Chemical, catalogue no. 765001), based on the synthetic substrate diheptanoyl thiophosphorylcholine, was used routinely for monitoring phospholipase activity. A third assay system, employing the synthetic radioactively labelled glycerophospholipids
, were used to determine the ester bond position specificity and substrate preferences of His 6 -p15. Enzyme reactions were conducted at 30
• C for various lengths of time (10-30 min) in 150 µl of reaction mixtures containing 140 mM NaCl, 0.1 % Triton X-100, 15 mM CaCl 2 , 20 mM Hepes/KOH (pH 8.0), 0.1 µCi of each radioactive, sn-2-position-labelled phospholipid, plus the corresponding unlabelled phospholipid (40 µM), and various amounts (5-10 nM) of His 6 -p15. Assays conducted in the absence of Ca 2+ (plus 2 mM EDTA) or in the presence of increasing concentrations of CaCl 2 (0.1-100 mM) were used to determine the Ca 2+ dependence of His 6 -p15. The pH optimum for activity was determined using 20 mM sodium acetate buffer for pH values ranging from 4.3 to 6.5, and 20 mM Hepes/KOH from pH 7 to 9. The dual-labelled phospholipid
, was used to assay for lysophospholipase activity. After blockage with 0.1 M EDTA/ 2 M NaCl (150 µl), organic solvent extraction [19] and TLC fractionation [20] , reaction products were visualized and quantified by Phosphorimaging as described previously [8] .
PC12 cell culture and neurite outgrowth assay
Rat pheochromocytoma PC12 cells were maintained in DMEM (Dulbecco's modified Eagle's medium; high-glucose type; Invitrogen) supplemented with 5 % horse serum and 5 % fetal calf serum. Cells were passaged every 3-4 days and maintained at 37
• C in 10 % CO 2 in humidified air. In a typical neurite-induction experiment, PC12 cells were seeded in the growth medium at 4.5 × 10 3 cells/cm 2 in collagen type I-coated 24-well culture plates (Becton Dickinson), allowed to grow for 24 h, and then supplemented with each of the various protein and/or non-protein additives specified in the text. When the culture supernatants of COS1 cells transfected with each sPLA 2 construct were examined for the neuritogenic activity, they were adjusted to 5 % fetal calf serum and 5 % horse serum by 2-fold dilution with fresh DMEM containing 10 % horse serum, and were directly applied to the PC12 cell cultures. After 48 h, neurite outgrowth was quantified by taking five random photographs/well; cells bearing processes longer than the cell diameter were judged as positive. 3 H]oleic acid (0.5 µCi/ml) in 500 µl of DMEM containing sera. After washing three times with DMEM without serum, cells were treated with p15, Scp15 or rbvPLA 2 for the indicated times at 37
• C. Culture media were then recovered, and cells were solubilized in 250 µl of 2 % Triton X-100. Both culture media and cell lysates (250 µl each) were mixed with 5 ml of scintillation cocktail, followed by radioactivity measurement in a liquid scintillation counter. The fraction of total radioactive fatty acid released into the culture medium by phospholipase action was calculated by dividing total counts present in the medium by the sum of the counts measured in the medium and in the corresponding cell lysate; background radioactivity measured in phospholipase-unsupplemented, control incubations was subtracted from each datapoint.
RESULTS
Identification of p15 as a sPLA 2 The closest homologue of p15 is a putative open reading frame from S. coelicolor A3(2) (CAB38593) named Scp15 [15] . They are similar in size (15 and 14 kDa for the N-terminally processed forms of p15 and Scp15, respectively) and both have four cysteine residues at conserved positions. Similar to p15, recombinant Scp15 also displays a dose-dependent neurite-inducing activity in PC12 cells, indicating that both proteins share structural as well as functional features [15] . Further search of the nucleotide and protein sequence databases revealed another p15/Scp15 homologue in S. coelicolor A3(2) (CAB96033) and one in Streptomyces violaceoruber (E08479), which has been identified recently as the first prokaryotic PLA 2 [11] (Figure 1A ). Additional homologous sequences were found in other micro-organisms, such as the filamentous ascomycete Tuber borchii, where the TbSP1 polypeptide (AF162269; Figure 1A ) has been recognized as the first Ca 2+ -dependent sPLA 2 to be described in fungi [10] . As further shown in Figure 1 (B) , all these proteins contain either an experimentally documented (p15, TbSP1) or a putative (Scp15, CAB96033) N-terminal signal sequence. These observations prompted us to test whether p15 is a PLA 2 , and whether neurite induction by p15 is correlated with its phospholipid-hydrolysing activity. As revealed by the results of the in vitro assays reported in Figure 2 (A), we found that His 6 -p15, the N-terminally His 6 -tagged form of the recombinant p15 polypeptide produced in E. coli, indeed exhibits a Ca 2+ -dependent lipid-hydrolysing activity toward [ 3 H]oleic acid-labelled E. coli membranes, with maximum activity in the presence of 1-2 mM CaCl 2 . A Ca 2+ -dependent phospholipase activity of both p15 and Scp15 was also revealed by independent in vitro assays employing arachidonoyl thio-phosphocholine as a substrate (results not shown). Similar results, albeit with an approx. 10-fold higher optimum Ca 2+ concentration, were obtained in a third set of assays conducted on His 6 -p15 at an optimum pH of 8.0, using synthetic dipalmitoyl-L-α-PC derivatives carrying 1-14 C-labelled palmitoyl groups at defined stereochemical positions. As shown in Figure 2(B) , [ 14 C]PA (palmitic acid), rather than 2-[ 14 C]palmitoyllysoPC, was the only product released from 1-palmitoyl-2- Altogether, these results demonstrate that p15 is an authentic PLA 2 , lacking any strict specificity for the fatty acyl or polar head group moieties of its phospholipid substrates.
Fatty acid-release from PC12 cells by p15 and Scp15
The ability of exogenously added p15 or Scp15 to liberate fatty acids from live PC12 cells was next investigated by adding either of the two recombinant proteins to the culture medium of PC12 cells that had been pre-labelled with [ 3 H]arachidonic or [ 3 H]oleic acid, followed by the measurement of radioactivity in culture supernatants as well as in total cell lysates. As shown in Figure 3 (A), p15 catalysed fatty acid release in a time-dependent manner. In keeping with the previously documented ability of p15 to act on variously substituted phospholipid substrates, arachidonic and oleic acids were released with nearly equal efficiencies, thus further supporting the notion that p15, like other sPLA 2 s, has no strict fatty acyl selectivity ( Figures 3B and  3C) . A similar lack of fatty acid selectivity was observed for Scp15, even though the extent of fatty acid release by p15 was slightly higher than that by Scp15, which is consistent with our previous observation that p15 is a more potent neurite inducer than Scp15 [15] . In both cases, the release of fatty acids was not due to PLA 2 -induced cell lysis, because the amount of total lactate dehydrogenase activity (a cytosolic marker) in the culture medium supernatants was usually very low and essentially the same in control and p15-or Scp15-treated PC12 cells (results not shown).
The PLA 2 activity of p15 is required for neuritogenesis Next, we asked whether the catalytic activity of p15 is required for neurite formation. For this purpose, the mutant versions of His 6 -p15, HDAA, D107A, C38/54S and C90/102S, were generated ( Figure 4A ), and tested for their catalytic and neuriteinducing activities. In the HDAA mutant, the catalytic His-57-Asp-58 dyad (amino acid residues are numbered from the N-terminus of the mature p15 protein) was replaced by two alanine residues. Similarly, in the D107A mutant, the Asp at position 107, which corresponds to the critical Asp-99 residue of mammalian sPLA 2 s [23] , was replaced by an alanine. In each of the C38/54S and C90/102S mutants two pairs of cysteines, previously shown to be involved in disulphide bond formation [13] , were simultaneously replaced by serine residues. As revealed by PLA 2 activity assays conducted on each of these mutants with the synthetic substrate diheptanoyl thiophosphorylcholine (Figure 4B ), HDAA and C38/54S exhibited essentially no enzymic activity, the D107A mutant retained approx. 60 % of wild-type activity, while, unexpectedly, the C90/102S mutant exhibited a PLA 2 activity 1.4-fold higher than that of wild-type His 6 -p15 ( Figure 4B ). When fatty acid-release from live PC12 cells by wild-type or mutant p15 proteins was examined ( Figure 4C ), a substantial reduction of both arachidonate and oleate release was observed in the case of the HDAA and C38/54S mutants.
In contrast, only a modest decrease or nearly wild-type levels of fatty acid releasing activity were measured for the C90/102S and D107A mutants, respectively. Finally, as shown in Figure 4(D) , we found that the neurite-outgrowth-inducing activity , were incubated with 10 nM His 6 -p15 (added directly to the culture medium) for the times indicated. The culture medium was then recovered and the cells lysed in 2 % Triton X-100; for each data point, radioactivity was measured both in the culture medium and the corresponding cell lysate (see the Experimental section for details). Radiolabelled fatty acid release into the culture medium is expressed as the percentage of total (released and cell-associated) radioactivity, calculated by dividing the counts present in the medium by the sum of the counts measured in the medium and in the corresponding cell lysate; background radioactivity measured in His 6 -p15-unsupplemented control incubations was subtracted from each data point. of wild-type and mutant p15 proteins matches quite closely their ability to release fatty acids from live PC12 cells. The HDAA and C38/54S mutations completely abolished neuritogenesis, while no loss of neurite inducing activity, or an approx. 40 % reduction (at 10 nM) of neuritogenic activity compared with wild-type p15 were observed in the case of the D107A and C90/102S mutants, respectively. Therefore, with the sole exception of the C90/102S mutant which displayed a higher PLA 2 than neurite-inducing activity, there is a fairly good correlation between PLA 2 , and fatty acid releasing-and neurite-inducing activities, implying that the catalytic activity of p15 is essential for neuritogenesis.
Phospholipase activity-dependent neuritogenesis induced by bvPLA 2 If p15 induces neurite outgrowth through its PLA 2 activity, one would expect that other sPLA 2 s should also be capable of inducing neurites. This possibility was examined by testing the neuritogenic activity of a group III sPLA 2 from honey bee venom (bvPLA 2 ). As shown in Figure 5 (A), a commercially available preparation of natural bvPLA 2 potently induced neurites in PC12 cells; at a concentration as low as 0.1 nM, which was almost completely ineffective for either p15 or Scp15, bvPLA 2 potently induced neurites ( Figure 5B ). Moreover, unlike p15 or Scp15, bvPLA 2 exhibited cytotoxicity at concentrations higher than 10 nM, which is probably the reason for the reduction in neurite-inducing activity observed at these bvPLA 2 concentrations. To find out whether the PLA 2 activity of bvPLA 2 is required for neurite induction, we isolated the bvPLA 2 cDNA from the venom gland of honey bee, and produced histidine-tagged, wildtype and mutant (H34A) versions of the honey bee enzyme in E. coli. In the H34A mutant, the catalytic His at position 34 [21] was replaced by an Ala residue. Both forms of the recombinant bvPLA 2 enzyme were almost completely insoluble in E. coli and were purified by inclusion-body solubilization, Immunoblot analysis (A) and neuritogenic activity assay (B) of the supernatants of COS1 cells expressing recombinant (HA-tagged) group IB, IIA, V and X mouse sPLA 2 s, and the active-site mutants of group V (Vm) and X (Xm) enzymes (see the Experimental section for details). Equal amounts of each culture supernatant were subjected to the standard PC12 neurite-outgrowth assay, as specified for Figure 4 
(D).
followed by Ni 2+ -agarose chromatography under denaturing conditions and subsequent renaturation. Even though the enzymic activity of recombinant wild-type bvPLA 2 (rbvPLA 2 ) towards the synthetic substrate diheptanoyl thiophosphorylcholine was significantly lower than that of the natural honey bee venom PLA 2 ( Figure 5B), both enzymes induced neurite outgrowth in PC12 cells in a dose-dependent manner ( Figure 5C ). Again, PLA 2 activity correlated quite well with both neurite-inducing and arachidonic acid-releasing activities ( Figure 5D ). Instead, the catalytically inactive rbvPLA 2 H34A mutant completely lacked neurite-inducing and fatty acid-releasing activities, thus further supporting the existence of a strong correlation between neuriteinduction and PLA 2 activity.
Induction of neurite outgrowth by mammalian sPLA 2 s
We next wished to find out whether mammalian sPLA 2 s also display neuritogenic activity. To address this question, we cloned mouse group IB, IIA, V and X sPLA 2 s and expressed them as C-terminally HA epitope-tagged proteins in COS1 cells, whose culture supernatants were assayed for recombinant sPLA 2 expression and neurite-induction activity. As shown in Figure 6 (A), group IB and IIA sPLA 2 s were both expressed at fairly high levels, while expression of the group V and X enzymes was barely detectable. The PLA 2 activities, examined with the [ 3 H]oleic acidlabelled E. coli membrane assay, of culture supernatants containing IB and IIA sPLA 2 s were higher than those containing group V or X, which paralleled the amount of each recombinant sPLA 2 produced (results not shown). However, when the same culture supernatants were assayed for neurite-induction activity, a prominent neuritogenic effect was observed with culture supernatants containing group V and X, but not group IB and IIA, sPLA 2 s ( Figure 6B ). As further shown in Figure 6(B) , culture supernatants containing the catalytic mutant forms of group V and X sPLA 2 s (respectively, H47A and H46A, in which the activesite His was replaced by an Ala residue) elicited a substantially reduced neuritogenic effect. Although the lack of a neuritogenic effect by group IB and IIA sPLA 2 s was somewhat unexpected (see the Discussion), the impairment of neuritogenic activity observed with group V and X mutants indicates once again that PLA 2 activity is essential for the neurite outgrowth response of PC12 cells.
Calcium-dependent neuritogenic activity of exogenously supplied PLA 2 hydrolysis products
It has been reported that arachidonic acid formation is involved in CAM-dependent neurite outgrowth both in PC12 cells and in cerebellar neurons [4] . In fact, homophilic binding of CAMs initiates a signalling cascade that, through the activation and tyrosine phosphorylation of fibroblast growth factor receptor, leads to the production of arachidonic acid via diacylglycerol lipase-catalysed diacylglycerol hydrolysis. Arachidonic acid thus produced is thought to promote the opening of L-and/or N-type Ca 2+ channels and to induce neurite outgrowth through as yet unknown mechanisms. Furthermore, the direct addition of arachidonic acid to the culture medium of cerebellar neurons or PC12 cells grown on a fibroblast monolayer also stimulated neurite outgrowth. Since neurite outgrowth induction by either microbial (p15, Scp15) or animal (bvPLA 2 ) sPLA 2 s, but not NGF-induced neuritogenesis, has been found to be sensitive to the L-type Ca 2+ channel inhibitor nicardipine ( Figure 7A ) as well as to nifedipine and nimodipine (results not shown), it was conceivable to imagine that sPLA 2 -induced neuritogenesis might be mediated by an arachidonic aciddependent mechanism. This possibility was tested by examining the possible neuritogenic effect of exogenously supplied arachidonic acid, directly added to the culture medium of PC12 cells, in the presence or absence of p15. As shown in Figure 7(B) , arachidonic acid, even though it was readily incorporated by PC12 cells (see Figure 3) , did not induce neurites or enhance p15-dependent neuritogenesis in our assay system. Also without effect was the diacylglycerol lipase inhibitor RHC-80267, which blocks CAM-induced neuritogenesis by interfering with arachidonic acid release [4] (results not shown).
Having found that arachidonic acid release itself is not a determining factor in PC12 cell neuritogenesis, we asked whether bioactive derivatives of arachidonic acid, such as prostaglandins or leukotrienes, might be involved in sPLA 2 -induced neurite outgrowth. The effect on PC12 neuritogenesis of inhibitors of COX (cyclo-oxygenase) and LOX (lipoxygenase), two key enzymes of arachidonic acid metabolism, was thus examined. As shown in Figure 7 (C), neither aspirin nor indomethacin, inhibitors of COX-1 and COX-1/2 respectively, had any detectable effect on p15-induced neuritogenesis, even though both drugs (at equivalent or even lower concentrations) were previously shown to inhibit kainic acid-induced prostaglandin E 2 generation in mouse cortical neurons [22] . Also without any effect were NDGA, an inhibitor of both 5-and 12-LOX, the 5-LOX inhibitor AA-861, and the 12-LOX inhibitor baicalein, which was previously shown to block NGF-induced neurite outgrowth in PC12 cells [23] (Figure 7D ). Altogether, these results indicate that arachidonic acid and its bioactive metabolites neither mimic nor affect sPLA 2 -induced neuritogenesis.
We then focused on a possible pro-neuritogenic role of lysophospholipids, the other product of PLA 2 -catalysed phospholipid hydrolysis. We found that 2-lysoPC, but no other 2-lysophospholipids, such as lysophosphatidylinositol, lysophosphatidylethanolamine, lysophosphatidylserine and lysophosphatidic acid, nor sphingosylphosphorylcholine (also known as lysosphingomyelin), induced neurite outgrowth when added to the culture medium of PC12 cells at 100 µM ( Figure 8A ). The plateletactivating factor receptor agonist mcPAF also did not exert any neuritogenic effect ( Figure 8A ). As shown in Figure 8(B) , the neuritogenic response induced by lysoPC was dose-dependently blocked by nicardipine to the same extent as nicardipine inhibition of sPLA 2 -induced neuritogenesis (cf. 7A and 8B). This suggests that 2-lysoPC (either exogenously added or generated in situ by sPLA 2 -catalysed PC hydrolysis) acts through an L-type Ca 2+ channel-dependent mechanism. As in the case of sPLA 2 -promoted neurite outgrowth, no synergistic enhancement of lysoPC-induced neuritogenesis was produced by the co-addition of 100 µM arachidonic acid (results not shown).
DISCUSSION
We have shown here that a secreted fungal protein named p15, a potent inducer of neurite outgrowth in PC12 cells, is an sPLA 2 capable of releasing fatty acids from membrane phospholipids of live PC12 cells. Neurite induction by p15 requires its PLA 2 activity. In fact, the two mutants with the most strongly reduced phospholipase activity (HDAA and C38/54S) also displayed the strongest reduction in neurite-induction activity. The possibility that the introduced mutations may have altered other properties of p15, besides catalytic activity, cannot be ruled out completely. However, the fairly close matching between in vitro phospholipid hydrolysis, fatty acid release from PC12 cells and neuritogenic activities of wild-type and mutant forms of p15 strongly suggests that PLA 2 activity (especially towards choline polar-headgroup phospholipids; see below) is the primary if not the sole determinant of p15-induced neuritogenesis. Further support to the notion that PLA 2 activity is absolutely required for neurite induction was provided by the observation that sPLA 2 s from either closely or distantly related organisms, for example Scp15 from S. coelicolor A3(2), TbSP1 from T. borchii ( [8] , and M. Arioka and S. Ottonello, unpublished work), wild-type bvPLA 2 and mouse group V and X sPLA 2 s, but not their active site mutants, also elicited neuritogenesis.
We have found that sPLA 2 -, but not NGF-induced neuritogenesis is blocked by L-type Ca 2+ -channel inhibitors. This finding is reminiscent of the results of previous studies showing that CAM-but not NGF-mediated neurite outgrowth depends on the activity of L-and N-type Ca 2 + channels and is accompanied by arachidonic acid release [4] . At variance with such studies, however, we find that exogenously supplied arachidonic acid (which was effectively incorporated by PC12 cells and readily released from them upon p15 action) neither caused neurite outgrowth nor stimulated p15-induced neuritogenesis. Also, neither COX nor LOX inhibitors were capable of preventing neurite outgrowth induction by p15. In contrast, 2-lysoPC, but not other lysophospholipids (nor platelet-activating factor), potently induced neurites in a nicardipine-sensitive manner, strongly suggesting that lysoPC triggers neurite outgrowth through the same mechanism underlying sPLA 2 -induced neuritogenesis. The striking lysophospholipid specificity of this effect might explain the inability of group IB and IIA sPLA 2 s, but not of group V and X enzymes, to promote neurite outgrowth. The latter two enzymes, in fact, have been shown to display a much higher specific activity (up to 60-fold) toward phosphatidylcholine compared with group IB and IIA sPLA 2 s [24] . Indeed, at variance with their lack of neurite induction activity on intact PC12 cells, recombinant group IB and IIA enzymes were both catalytically active when assayed on heat-killed [ 3 H]oleic acid-labelled bacterial cells, which are known to contain mainly phosphatidylethanolamine and anionic phospholipids, but not PC, among their surface lipid constituents (results not shown). So, even though other features of this set of mammalian sPLA 2 s (e.g. their ability to interact with PC12 cells, either non-specifically or through specific receptors) may contribute to their differential ability to induce neurite outgrowth, it appears that a high hydrolytic activity towards PC and the consequent production of adequate amounts of lysoPC represents a key requirement for their neuritogenic effect. These data also suggest that different groups of mammalian sPLA 2 s may be involved in profoundly different responses. For example, a type II sPLA 2 (presumably belonging to the same IIA group we find to be inactive in neurite induction) was reported to be involved in degranulation of, and catecholamine secretion by, NGF-treated neuronally differentiated PC12 cells [25] .
How does lysoPC induce neurite outgrowth? This PC derivative has been shown to be specifically involved in a variety of cellular responses such as activation of phospholipase C and protein kinase C, increase in intracellular Ca 2+ concentration ([Ca 2+ ] i ), and activation and inhibition of MAPK [26] . Interestingly, we found previously that an activation of the Src-Ras-MAPK cascade, which is known to occur through membrane depolarization, is induced upon p15 treatment, whereas the expression of a dominant-negative form of Ras or the addition of the MAPK kinase inhibitor PD98059 blocks neuritogenesis elicited by p15 [13, 14] . At least some of the effects of lysoPC are likely to be mediated by the recently identified G protein-coupled lysoPC receptors G2A and GPR4 [27, 28] , which in response to lysoPC induce the release of calcium ions from intracellular stores through a G i -dependent mechanism. We do not know, at present, whether the neuritogenic effect of lysoPC is mediated by G2A or GPR4 receptors, or by another type of receptor. It should be noted, however, that such an effect takes place at lysoPC concentrations (10-100 µM) that are well above the apparent K d values of these receptors for lysoPC (65-160 nM), and that lysoPC, also at micromolar concentrations, exerts neurotrophic effects on cerebellar granule neurons in vitro and on hippocampal neurons in vivo [29] . Various explanations can be imagined for this concentration discrepancy; including, for example, the sequestration by albumin or other serum proteins (present in the culture medium) of lysoPC, which would then become unavailable for receptor interaction and response activation. Indeed, the addition of an excess of BSA to immortalized MCF10A cells blocked the [Ca 2+ ] i increase induced by lysoPC upon interaction with the GPR4 receptor [28] .
At variance with the neurite-inducing activity of sPLA 2 s demonstrated in this study, which is reminiscent of the action(s) of neurotrophic factors (such as NGF and basic fibroblast growth factor) on PC12 cells, it has been reported that mammalian group IB and IIA sPLA 2 s can promote apoptotic cell death in primary cultures of rat cortical neurons [30, 31] . The same effect, however, was also produced by an anti-sPLA 2 receptor antibody, as if receptor binding itself, rather than phospholipase activity, were chiefly responsible for cell-death induction in this system [32] . On a similar note, the OS2 but not the OS1 sPLA 2 from taipan snake venom caused extensive histological damage when co-injected with glutamate into rat brain, and the same enzyme was found to increase glutamate-induced cell death and intracellular Ca 2+ concentration, along with an enhanced arachidonic acid mobilization, in primary neuronal cell cultures [33, 34] . A glutamate-independent cell-death effect, involving the activation of a cytosolic PLA 2 , arachidonic acid release, platelet-activating factor production and induction of COX-2, was also reported to occur in neuronal cell cultures exposed to neurotoxic concentrations of the OS2 phospholipase [35] . Whether or not these neurotoxic and pro-apoptotic effects of sPLA 2 s are relevant to our results is presently unclear. It is likely, however, that different sPLA 2 s can perform distinct functions depending on their biochemical properties, dosage and mode of delivery, and on the particular cellular context (e.g. neuronal cell cultures versus undifferentiated PC12 cells) in which they are examined. Following up to this initial demonstration of a Ca 2+ -and lysoPCdependent differentiation role of sPLA 2 s, further studies will be needed to gain a more detailed understanding of the mode of action and of the full complement of physiological roles played by these enzymes in mammalian cells, especially those in the nervous system.
